Bisantrene

DB17247InvestigationalSmall molecule

Bisantrene: Overview.

Chemical structure of Bisantrene
Mechanism
Curator reviewed
Formula / weight
C22H22N8 · 398.474 g/mol (avg)
Also known as
9,10-anthracenedicarboxaldehyde bis(2-imidazolin-2-ylhydrazone) · 9,10-anthracenedicarboxaldehyde, bis((4,5-dihydro-1h-imidazol-2-yl)hydrazone)

Resolves to

Compound
UNII39C34M111KCAS78186-34-2ChEMBLCHEMBL25336
Structure
InChIKeyNJSMWLQOCQIOPE-OCHFTUDZSA-NSMILESC1CN=C(N\N=C\C2=C3C=CC=CC3=C(\C=N\NC3=NCCN3)C3=C2C=CC=C3)N1
Targets
Q9C0B1FTO

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bisantrene, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In